A new hydrogel can incorporate high cell density constructs to better mimic the rearrangement of native tissue in bioengineering.
A new tissue regeneration strategy that employs direct cell reprogramming in combination with a new hybrid scaffold shows promise in proof-of-concept study.
Graphene-based biosensors incorporated in arrays of microneedles are emerging as an alternative to hypodermic needles and could be the next generation of blood sampling devices.
Using a more sophisticated analysis, researchers aim to set better baselines for clinical trials exploring therapeutics for patients with celiac disease.
A new microwell chip holds promise for screening immunotherapy drugs with the added bonus that it can include a patient’s own cells for optimized treatment planning.
Engineers and oncologists teamed up to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.
Sprayed on and held in place like Velcro, researchers develop a dynamic hydrogel barrier system to improve the outcome of invasive surgery and reduce the need for additional operations.
Nvel tuberculosis vaccine demonstrated strong immune response in mice.
The first digital CRISPR/Cas‐assisted assay that can detect SARS‐CoV‐2 in under 30 minutes.
Scientists investigated phages that can kill the world’s leading superbug, Acinetobacter baumannii, which is responsible for up to 20% of infections in intensive care units.